Clinical trials in Albany, NY

49 recruiting studies have a site in or near Albany, NY, New York.

Top conditions here

All conditions

Showing 40 of 49 studies

RecruitingPhase 3NCT06345729

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Sponsor: Merck Sharp & Dohme LLC

Albany, NY · +14 more sites

RecruitingPhase 3NCT07654374

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Albany, NY · Brooklyn, NY · +71 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Albany, NY · Buffalo, NY · New Hyde Park, NY · +112 more sites

RecruitingPhase 3NCT07513376

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Sponsor: Merck Sharp & Dohme LLC

Albany, NY · Syracuse, NY · White Plains, NY · +21 more sites

RecruitingPhase 2NCT07683325

NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease

Sponsor: Agomab Spain S.L.U.

Albany, NY · +4 more sites

RecruitingPhase not listedNCT06297291

Global Paradise System US Post Approval Study

Sponsor: ReCor Medical, Inc.

Albany, NY · Brooklyn, NY · Buffalo, NY · +43 more sites

RecruitingPhase 3NCT07365995

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Sponsor: BioNTech SE

Albany, NY · White Plains, NY · +19 more sites

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Albany, NY · Binghamton, NY · Buffalo, NY · +205 more sites

RecruitingPhase not listedNCT02071134

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Sponsor: Boston Scientific Corporation

Albany, NY · Great Neck, NY · Williamsville, NY · +26 more sites

RecruitingPhase 3NCT06136559

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Sponsor: Merck Sharp & Dohme LLC

Albany, NY · Buffalo, NY · Williamsville, NY · +46 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Albany, NY · Brooklyn, NY · +163 more sites

RecruitingPhase 3NCT06307665

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Sponsor: AstraZeneca

Albany, NY · Cortland, NY · Hawthorne, NY · +117 more sites

RecruitingPhase 3NCT06736574

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Sponsor: Cytokinetics

Albany, NY · Manhasset, NY · New York, NY · +85 more sites

RecruitingPhase 3NCT07667803

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Sponsor: AstraZeneca

Albany, NY · Laurelton, NY · Long Island City, NY · +53 more sites

RecruitingPhase 3NCT06976203

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Sponsor: Bristol-Myers Squibb

Albany, NY · Amherst, NY · Buffalo, NY · +28 more sites

RecruitingPhase 2NCT07033494

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Sponsor: Merck Sharp & Dohme LLC

Albany, NY · New Windsor, NY · Queens, NY · +33 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Albany, NY · Brooklyn, NY · New York, NY · +126 more sites

RecruitingPhase 3NCT07222566

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Sponsor: Pfizer

Albany, NY · Clifton Park, NY · Nyack, NY · +223 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Albany, NY · Auburn, NY · Babylon, NY · +251 more sites

RecruitingPhase not listedNCT03664609

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor: Boston Scientific Corporation

Albany, NY · +9 more sites

RecruitingPhase 2NCT06847321

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Sponsor: Lighthouse Pharmaceuticals, Inc.

Albany, NY · New York, NY · +37 more sites

RecruitingNot applicableNCT07069738

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Sponsor: Boston Scientific Corporation

Albany, NY · Flushing, NY · New York, NY · +39 more sites

RecruitingPhase 1 / Phase 2NCT06189963

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

Sponsor: NKGen Biotech, Inc.

Albany, NY · +6 more sites

RecruitingPhase 3NCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Albany, NY · Bronxville, NY · +232 more sites

RecruitingPhase 1 / Phase 2NCT06619990

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Sponsor: Xencor, Inc.

Albany, NY · Rochester, NY · +28 more sites

RecruitingPhase 2NCT07845487

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Palisade Bio

Albany, NY · Rochester, NY · +28 more sites

RecruitingPhase 2 / Phase 3NCT06976268

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Sponsor: Biohaven Therapeutics Ltd.

Albany, NY · New York, NY · +22 more sites

RecruitingPhase 3NCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Sponsor: AstraZeneca

Albany, NY · Buffalo, NY · New York, NY · +130 more sites

RecruitingPhase 4NCT07633470

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Sponsor: Alpha Cognition, Inc

Albany, NY · +19 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Albany, NY · Brooklyn, NY · Buffalo, NY · +183 more sites

RecruitingPhase 3NCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Sponsor: Amgen

Albany, NY · New York, NY · Poughkeepsie, NY · +118 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Albany, NY · Brooklyn, NY · +195 more sites

RecruitingPhase 3NCT06056830

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Sponsor: Clarity Pharmaceuticals Ltd

Albany, NY · New York, NY · +27 more sites

RecruitingNot applicableNCT07599982

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Sponsor: DreaMed Diabetes

Albany, NY · +5 more sites

RecruitingPhase not listedNCT02418442

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Sponsor: Duke University

Albany, NY · Lake Success, NY · New York, NY · +72 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Albany, NY · Brooklyn, NY · Mineola, NY · +161 more sites

RecruitingPhase not listedNCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Sponsor: Children's Oncology Group

Albany, NY · Buffalo, NY · The Bronx, NY · +69 more sites

RecruitingPhase 3NCT07567001

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Sponsor: Novo Nordisk A/S

Albany, NY · Brooklyn, NY · New York, NY · +203 more sites

RecruitingPhase 3NCT07654361

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Albany, NY · Brooklyn, NY · +69 more sites

RecruitingPhase 3NCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Sponsor: Greenwich LifeSciences, Inc.

Albany, NY · New York, NY · Stony Brook, NY · +48 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.